Pesquisas alternativas:
after force » after forced (Expandir a Pesquisa), after forceps (Expandir a Pesquisa), after source (Expandir a Pesquisa)
force phase » source phase (Expandir a Pesquisa), force plate (Expandir a Pesquisa), force base (Expandir a Pesquisa)
after force » after forced (Expandir a Pesquisa), after forceps (Expandir a Pesquisa), after source (Expandir a Pesquisa)
force phase » source phase (Expandir a Pesquisa), force plate (Expandir a Pesquisa), force base (Expandir a Pesquisa)
1
Por Beeh, Kai-Michael, LaForce, Craig, Gahlemann, Martina, Wenz, Arne, Toorawa, Robert, Fležar, Matjaž
Publicado no Respir Res (2015)
“... comparing the 24-h forced expiratory volume in 1 s (FEV(1)) time profile after 3 weeks’ treatment with once...”Publicado no Respir Res (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
Por Hopkins, Robert J., Daczkowski, Nancy F., Kaptur, Paulina E., Muse, Derek, Sheldon, Eric, LaForce, Craig, Sari, Suha, Rudge, Thomas L., Bernton, Edward
Publicado em 2013
“... of injections needed for protection would be desirable in a post-exposure setting. This Phase 1 study compared...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Findlow, H., Plikaytis, B. D., Aase, A., Bash, M. C., Chadha, H., Elie, C., Laher, G., Martinez, J., Herstad, T., Newton, E., Viviani, S., Papaspyridis, C., Kulkarni, P., Wilding, M., Preziosi, M. P., Marchetti, E., Hassan-King, M., La Force, F. M., Carlone, G., Borrow, R.
Publicado em 2009
“...A double-blind, randomized, controlled phase I study to assess the safety, immunogenicity...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Gotfried, Mark H., Girod, Carlos E., Antin-Ozerkis, Danielle, Burgess, Tracy, Strombom, Indiana, Stauffer, John L., Kirchgaessler, Klaus-Uwe, Padilla, Maria L.
Publicado no Pulm Ther (2018)
“...INTRODUCTION: PIPF-002 was a phase 2, multicenter, open-label study of pirfenidone in patients...”Publicado no Pulm Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Miller, Robert G., Block, Gilbert, Katz, Jonathan S., Barohn, Richard J., Gopalakrishnan, Vidhya, Cudkowicz, Merit, Zhang, Jane R., McGrath, Michael S., Ludington, Elizabeth, Appel, Stan H., Azhir, Ari
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)
“...OBJECTIVE: To assess the safety, tolerability, and preliminary efficacy of NP001, a novel immune...”Publicado no Neurol Neuroimmunol Neuroinflamm (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Tao Wang, Weihong Kuang, Wei Chen, Wenwei Xu, Liming Zhang, Yingjie Li, Hailin Li, Ying Peng, Yangmei Chen, Baojun Wang, Jinsong Xiao, Honghua Li, Chuanzhu Yan, Yifeng Du, Mouni Tang, Zhiyi He, Haibo Chen, Wei Li, Hong Lin, Shugui Shi, Jianzhong Bi, Huadong Zhou, Yan Cheng, Xiaoping Gao, Yihui Guan, Qiu Huang, Kewei Chen, Xianliang Xin, Jian Ding, Meiyu Geng, Shifu Xiao
Publicado em 2020-09-01
Assuntos:
“...Safety...”Publicado em 2020-09-01
Obter o texto integral
Artigo
7
Por Kipnes, Mark S., Handley, Alison, Lloyd, Eric, Barger, Bruce, Roberts, Andrew
Publicado no J Clin Hypertens (Greenwich) (2015)
“...A phase 3, 26‐week, open‐label, titrate‐to‐target study (n=418) assessed the safety of azilsartan...”Publicado no J Clin Hypertens (Greenwich) (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“... after the infusion of 100 mL saline. The serological markers tests were used to assess safety and the 28...”
Obter o texto integral
Obter o texto integral
Artigo
9
Por Beier, Jutta, Fuhr, Rainard, Seoane, Beatriz, Massana, Eric, de Miquel, Gonzalo, Pujol, Helena, Ruiz, Sandrine
Publicado no Pharmacol Res Perspect (2017)
“... of asthma and chronic obstructive pulmonary disease. We assessed the efficacy, safety, and tolerability...”Publicado no Pharmacol Res Perspect (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Singh, Dave, Kane, Binita, Molfino, Nestor A, Faggioni, Raffaella, Roskos, Lorin, Woodcock, Ashley
Publicado em 2010
“..., placebo-controlled phase 1 study in asthmatics (forced expiratory volume in 1 second [FEV(1)] ≥ 80...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Roskos Lorin, Faggioni Raffaella, Molfino Nestor A, Kane Binita, Singh Dave, Woodcock Ashley
Publicado em 2010-01-01
“... multiple-dose, randomised, double-blind, placebo-controlled phase 1 study in asthmatics (forced expiratory...”Publicado em 2010-01-01
Obter o texto integral
Artigo
12
Por Nabavi, Seyed Massood, Arab, Leila, Jarooghi, Neda, Bolurieh, Tina, Abbasi, Fatemeh, Mardpour, Soura, Azimyian, Vajihe, Moeininia, Fatemeh, Maroufizadeh, Saman, Sanjari, Leila, Hosseini, Seyedeh Esmat, Aghdami, Nasser
Publicado no Cell J (2019)
“... conducted two clinical trials to assess the safety and feasibility of intravenous (IV) and intrathecal...”Publicado no Cell J (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Seyed Massood Nabavi, Leila Arab, Neda Jarooghi, Tina Bolurieh, Fatemeh Abbasi, Soura Mardpour, Vajihe Azimyian, Fatemeh Moeininia, Saman Maroufizadeh, Leila Sanjari, Seyedeh Esmat Hosseini, Nasser Aghdami
Publicado em 2018-08-01
“... conducted two clinical trials to assess the safety and feasibility of intravenous (IV) and intrathecal...”Publicado em 2018-08-01
Obter o texto integral
Artigo
14
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety...
Por Tzouvelekis, Argyris, Paspaliaris, Vassilis, Koliakos, George, Ntolios, Paschalis, Bouros, Evangelos, Oikonomou, Anastasia, Zissimopoulos, Athanassios, Boussios, Nikolaos, Dardzinski, Brian, Gritzalis, Dimitrios, Antoniadis, Antonis, Froudarakis, Marios, Kolios, George, Bouros, Demosthenes
Publicado em 2013
“... of this dismal disease. PATIENTS AND METHODS: To this end, we conducted a phase Ib, non-randomized, clinical...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por McCormack, Francis X., Inoue, Yoshikazu, Moss, Joel, Singer, Lianne G., Strange, Charlie, Nakata, Koh, Barker, Alan F., Chapman, Jeffrey T., Brantly, Mark L., Stocks, James M., Brown, Kevin K., Lynch, Joseph P., Goldberg, Hilary J., Young, Lisa R., Kinder, Brent W., Downey, Gregory P., Sullivan, Eugene J., Colby, Thomas V., McKay, Roy T., Cohen, Marsha M., Korbee, Leslie, Taveira-DaSilva, Angelo M., Lee, Hye-Seung, Krischer, Jeffrey P., Trapnell, Bruce C.
Publicado em 2011
“... promise in phase 1–2 trials involving patients with LAM. METHODS: We conducted a two-stage trial...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Tashkin, Donald P, Doherty, Dennis E, Kerwin, Edward, Matiz-Bueno, Carlos E, Knorr, Barbara, Shekar, Tulin, Banerjee, Sibabrata, Staudinger, Heribert
Publicado em 2012
“...) investigated the efficacy and safety of a fixed-dose combination of MF/F. METHODS: This multicenter, double...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Beier, Jutta, Kirsten, Anne-Marie, Mróz, Robert, Segarra, Rosa, Chuecos, Ferran, Caracta, Cynthia, Gil, Esther Garcia
Publicado em 2013
“...BACKGROUND: This randomized, double-blind, Phase IIIb study evaluated the 24-hour bronchodilatory...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Waterer, Grant, Lord, John, Hofmann, Thomas, Jouhikainen, Taneli
Publicado no Antimicrob Agents Chemother (2020)
“... for inhalation (AeroVanc). Here, we report a phase I, single-dose, dose-escalating study aimed at demonstrating...”Publicado no Antimicrob Agents Chemother (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
“... of mammalian target of rapamycin (mTOR) signalling pathway. Sirolimus showed efficacy in a phase 3 trial...”
Obter o texto integral
Obter o texto integral
Artigo
20
Por Yoon, Hee-Young, Hwang, Jung Jin, Kim, Dong Soon, Song, Jin Woo
Publicado no Orphanet J Rare Dis (2018)
“... of mammalian target of rapamycin (mTOR) signalling pathway. Sirolimus showed efficacy in a phase 3 trial...”Publicado no Orphanet J Rare Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo